Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124069 · ClinicalTrials.gov registry record · NA
A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea
A NA study, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT03124069 is a NA study that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 37 participants.
The verdict
NCT03124069, a NA study, has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.
Interventions
- DEVICE F&P Saturn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03124069
The ClinicalTrials.gov registry entry for NCT03124069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which F&P Saturn is the first listed.
NCT03124069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03124069 about?
NCT03124069 is a clinical study titled "A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea". This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.
What is the current status of trial NCT03124069?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-04-24. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT03124069?
The interventions under investigation include: F&P Saturn (DEVICE).
Who is sponsoring clinical trial NCT03124069?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.